Skip to main content

fda_approval · anda · info

MSN — ANDA approval: CARFILZOMIB (unspecified)

Event date
2026-07-20 00:00:00Z
Observed
2026-07-24 04:30:40Z
Source ID
ANDA209526-1
Payload hash
d90223b6f3b409575c5db14d

Summary

MSN received ANDA approval for CARFILZOMIB (unspecified) on 2026-07-20. Dosage form: INJECTABLE. Application #: ANDA209526.

Entities

Frequently asked questions

Has MSN had other FDA enforcement actions?
Yes. Argus HQ has recorded 4 total FDA actions tied to MSN: 0 warning letters, 0 recalls, 4 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-20; Argus observed and indexed it on 2026-07-24.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). MSN — ANDA approval: CARFILZOMIB (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-msn-anda209526-1
MLA
"MSN — ANDA approval: CARFILZOMIB (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-msn-anda209526-1.
Chicago
Argus HQ Research. "MSN — ANDA approval: CARFILZOMIB (unspecified)." Digital Empire Holdings LLC. Accessed August 20, 2026. https://argushq.ai/events/fda-approval-msn-anda209526-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_msn_anda209526_1_2026,
  title = {MSN — ANDA approval: CARFILZOMIB (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-msn-anda209526-1},
  note = {Accessed: August 20, 2026}
}

Informational only. Not legal, financial, or medical advice.